Novavax COVID-19 vaccine study now includes kids, company says
Vaccine development company Novavax on Monday announced it has expanded its Phase 3 clinical trial for its COVID-19 vaccine to children between the ages of 12 and 17.
via FOX NEWS https://ift.tt/3thtriS
No comments:
Post a Comment
Thanks for your comment reply within 24 hours